Pairidex Using cutting-edge technology to establish itself as the sole supplier of thorough blood cancer detection
Pairidex has raised $4.9M in total funding. The most recent round was Seed. The last funding was announced in July 2026.
Pairidex's investors include BioGenerator Ventures.
Pairidex is headquartered in Duncan, United States.
Pairidex Using cutting-edge technology to establish itself as the sole supplier of thorough blood cancer detection
Pairidex is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pairidex — Funding & Investors." VCBacked, July 27, 2026, https://www.vcbacked.co/company/pairidex. Accessed October 7, 2026.
VCBacked. (2026). Pairidex — Funding & Investors. Retrieved October 7, 2026, from https://www.vcbacked.co/company/pairidex
{{cite web |title=Pairidex — Funding & Investors |url=https://www.vcbacked.co/company/pairidex |website=VCBacked |access-date=October 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated